Related Experiment Video
Updated: May 23, 2026
11:50
Ex vivo Mimicry of Normal and Abnormal Human Hematopoiesis
Published on: April 10, 2012
MiR-125 in normal and malignant hematopoiesis
1Department of Pediatric Hemato-Oncology, Functional Genomics and Childhood Leukemia Research, Cancer Research Center, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel.
Leukemia
|March 30, 2012
Summary
MicroRNA 125 (miR-125) is crucial in hematopoietic stem cells (HSCs), promoting survival and self-renewal. Dysregulated miR-125 expression in leukemia drives oncogenesis by blocking cell differentiation and promoting apoptosis resistance.
Area of Science:
- Molecular Biology
- Genetics
- Hematology
Background:
- MicroRNA 125 (miR-125) is a conserved non-coding RNA with three human homologs.
- miR-125 plays a significant role in regulating cellular processes.
Purpose of the Study:
- To review the role of miR-125 in normal and malignant hematopoietic cells.
- To elucidate the function of miR-125 in hematopoiesis and leukemia.
Main Methods:
- Review of recent research findings.
- Analysis of miR-125 expression patterns in various hematopoietic cell types.
- Examination of mouse models demonstrating miR-125's oncogenic role.
Main Results:
- High miR-125 expression in hematopoietic stem cells (HSCs) supports self-renewal and survival.
- Aberrant miR-125 expression in leukemias confers resistance to apoptosis and inhibits differentiation.
- Mouse models confirm a direct oncogenic function of miR-125 in the hematopoietic system.
Conclusions:
- miR-125 is a key regulator in both normal hematopoiesis and leukemogenesis.
- Targeting miR-125 may offer therapeutic strategies for hematologic malignancies.
More Related Videos
Related Concept Videos
01:21Hematopoiesis
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
01:20Overview of Hematopoiesis
Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
01:15Differentiation of Common Myeloid Progenitor Cells
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...